首页> 外文OA文献 >Coleopteran Antimicrobial Peptides: Prospects for Clinical Applications
【2h】

Coleopteran Antimicrobial Peptides: Prospects for Clinical Applications

机译:鞘翅目抗菌肽:临床应用前景。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antimicrobial peptides (AMPs) are activated in response to septic injury and have important roles in vertebrate and invertebrate immune systems. AMPs act directly against pathogens and have both wound healing and antitumor activities. Although coleopterans comprise the largest and most diverse order of eukaryotes and occupy an earlier branch than Drosophila in the holometabolous lineage of insects, their immune system has not been studied extensively. Initial research reports, however, indicate that coleopterans possess unique immune response mechanisms, and studies of these novel mechanisms may help to further elucidate innate immunity. Recently, the complete genome sequence of Tribolium was published, boosting research on coleopteran immunity and leading to the identification of Tribolium AMPs that are shared by Drosophila and mammals, as well as other AMPs that are unique. AMPs have potential applicability in the development of vaccines. Here, we review coleopteran AMPs, their potential impact on clinical medicine, and the molecular basis of immune defense.
机译:抗菌肽(AMPs)响应败血症性损伤而被激活,并且在脊椎动物和无脊椎动物免疫系统中具有重要作用。 AMP直接作用于病原体,具有伤口愈合和抗肿瘤活性。尽管鞘翅目在昆虫的全代谢谱系中构成了最大和最多样化的真核生物,并且比果蝇占据了更早的分支,但它们的免疫系统尚未得到广泛研究。但是,最初的研究报告表明,鞘翅目具有独特的免疫反应机制,对这些新机制的研究可能有助于进一步阐明先天免疫。最近,发表了Tribolium的完整基因组序列,从而促进了对鞘翅目免疫力的研究,并导致了果蝇和哺乳动物以及独特的其他AMP共同鉴定的Tribolium AMP。 AMP在疫苗开发中具有潜在的适用性。在这里,我们审查鞘翅目AMPs,它们对临床医学的潜在影响以及免疫防御的分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号